837 views | 7 years ago
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more...
291 views | 7 years ago
In this webinar, Dr. Jamuar discusses the optimal technique for the detection of somatic mosaicism. He evaluates the limitations of Sanger sequencing and highlights the advantages of targeted next-generation...
1658 views | 7 years ago
Phill joined Illumina in 2012 as a software systems engineer in Development. He designed and implemented instrumentation software for Illumina products and automated solutions for internal Iabs and...
2392 views | 7 years ago
Giovanna came to Illumina in 2005 looking to help shape the future of genomics as a systems engineer and project manager in Product Development. During this time, she worked on laboratory information...
1436 views | 7 years ago
Kat started at Illumina in 2011 as a scientist in Research and Development. She has since held positions in Consumables Product Development, Genomic Applications—where she worked on organ typing for...
1173 views | 7 years ago
Jay joined Illumina in 2006 as a scientist in Technical Support after completing a postdoctoral fellowship at The Scripps Research Institute. He has held positions in Product Support and Supply Chain,...
2905 views | 7 years ago
Tuuli Lappalainen, PhD, assistant professor at New York Genome Center and Columbia University, seeks to understand the connections between genetic variants and gene expression patterns. Studying genome-wide...
102 views | 7 years ago
In this webinar, Dr. Jamuar discusses the optimal technique for the detection of somatic mosaicism. He evaluates the limitations of Sanger sequencing and highlights the advantages of targeted next-generation...